ClinicalTrials.Veeva

Menu

Pulmonary Vein Isolation Outcomes With Fish Oils (PUFA)

S

St. Luke's-Roosevelt Hospital Center

Status

Conditions

Atrial Fibrillation

Treatments

Drug: Lovaza (Fish Oils)

Study type

Expanded Access

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

Fish oil therapy may decrease the incidence of cardiac arrhythmias. This study will test whether pre-treatment with fish oils before catheter ablation of atrial fibrillation decreases the early post operative occurrence of atrial fibrillation.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Paroxysmal Atrial fibrillation (PAF).
  • Persistent atrial fibrillation. Persistent AF is not self-limited.

Exclusion criteria

  • Previous pulmonary vein isolation ablation procedure
  • Contraindication for anticoagulation
  • Permanent AF
  • Severe valvular pathology
  • Concurrent use of antiarrhythmic medications
  • Inability to give consent
  • Pregnancy

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems